Typical clinico-pharmacological article
This information is a reference and it is not enough that the drug has been prescribed by a doctor ..
Antimalarial drug, disrupts the exchange of folic acid plasmodium. Has no hypoglycemic effect. Effective against toxoplasm.
Prevention and treatment:
- Pneumocystis infection (prophylaxis).
For the treatment of malaria appoint single doses: adults - 7.5 ml solution in ampoules or 3 tab., Children 10-14 years - 5 ml or 2 tab., Children 7-9 years - 3.5 ml or 1.5 tab., Children 4-6 years - 2.5 ml or 1 tab., Children under 4 years old - 1-1.5 ml or 1/2 tab.
The solution in the ampoules is injected / m, deep. To achieve a rapid therapeutic effect and prevent relapse, it is recommended to additionally prescribe quinine within 3-7 days.
For the prevention of malaria, patients with partial immunity are given a single dose of 2-3 tablets. 1 time in 4 weeks; patients who lack immunity , 1 tab. 1 time a week. Children depending on the age are prescribed 1 / 2-2 tablets. 1 time in 4 weeks. (with partial immunity) or 1 / 2-1.5 tab. 1 time in 2 weeks. (without immunity).
The first dose of the drug is taken 1 week before the departure to the endemic area, the reception continues for the entire period of stay in the area, as well as 6 more weeks after the return.
In case of toxoplasmosis to adults - 2 tab. Once a week, for 6-8 weeks.
For the prevention of pneumonia in infants and young children 40 mg / kg (calculated by the content of sulfadoxine) are prescribed once every 2 weeks; adults - 1-2 table. in Week.
A feeling of stomach overflow, nausea, vomiting, stomatitis, hepatitis, hematologic changes (leukopenia, thrombocytopenia, megaloblastic B 12- deficiency anemia, agranulocytosis, purpura), lethargy, headache, fever, polyneuritis, pulmonary infiltrates, cough, dyspnea, skin reactions rash, itching, hair loss, multiforme exudative erythema (including Stevens-Johnson syndrome), toxic epidermal necrolysis (Lyell's syndrome).
- Pregnancy (I trimester);
- the possibility of conception during the period of treatment;
- lactation period;
- early infancy (up to 2 months);
- Hepatic and / or renal insufficiency;
- oppression of bone marrow hematopoiesis.
PREGNANCY AND LACTATION
Contraindications: pregnancy (I trimester); the possibility of conception during the period of treatment; lactation period;
APPLICATION FOR FUNCTIONS OF THE LIVER
Contraindication is renal failure.
APPLICATION FOR VIOLATIONS OF THE FUNCTION OF KIDNEYS
Contraindication is liver failure.
APPLICATION FOR CHILDREN
Contraindication - early infancy (up to 2 months).
If necessary, administer the drug to children older than 2 months. you should carefully read the instructions for use of the drug (see section "Dosage regimen" and precautions).
Therapy with the drug for more than 3 months is carried out under the regular control of the blood picture. With prolonged use, simultaneous administration of folic acid is recommended.
When appearing against the background of cough or dyspnea treatment, the drug should be discarded.
Incompatible with trimethoprim or combinations of trimethoprim and sulfonamides (possibly increased folate deficiency with appropriate hematological changes).
When combined with chloroquine, side effects can be observed more often and in a more severe form.
TERMS OF RELEASE FROM PHARMACY
The drug is released by prescription.
TERMS AND CONDITIONS OF STORAGE
Keep out of the reach of children at a temperature of no higher than 35 В° C.